Metsera, Inc. MTSR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

39/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Metsera, Inc. (MTSR) reported total assets of $450.99M and total liabilities of $163.64M for fiscal year 2024, resulting in total equity of $287.35M.

The company held $352.45M in cash and short-term investments. Total debt stood at $9.8M, with net debt of $-342.65M. The Debt-to-Equity (D/E) ratio was 0.03 (conservative).

Current ratio is 5.34, indicating strong short-term liquidity. Interest coverage is -1008.2x (weak).

Criteria supported by this page:

HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
MOAT (40/100) — Total assets $450.99M and equity $287.35M support the company's competitive scale

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

39/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✓

FUTURE

75/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

40/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Metsera, Inc. Balance Sheet History

Metric	FY2024	FY2023	FY2022
Total Assets	$450.99M	$168.84M	$14.98M
Total Liabilities	$163.64M	$70.34M	$15.79M
Total Debt	$9.8M	$0.00	$15.18M
Cash & Investments	$352.45M	$75.2M	$14.98M
Total Stockholders Equity	$287.35M	$98.5M	$-813K